- Home
- PETS vs SER Comparison
PETS vs SER Comparison
Compare PETS & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PETS | SER |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Retail-Drug Stores and Proprietary Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 19.4M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | PETS | SER |
|---|---|---|
| Price | $2.43 | $1.46 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.20 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 95.0K | 65.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $273,800,000.00 | N/A |
| Revenue This Year | N/A | $134.46 |
| Revenue Next Year | $2.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $1.42 |
| 52 Week High | $4.32 | $7.92 |
Technical Indicators
Market Signals| Indicator | PETS | SER |
|---|---|---|
| Relative Strength Index (RSI) | 28.37 | 34.90 |
| Support Level | $2.44 | N/A |
| Resistance Level | $2.93 | $1.86 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 23.23 | 9.09 |
Price Performance
Historical ComparisonAbout PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.